183 results
8-K
EX-3.5
CRVO
CervoMed Inc
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
or represented by proxy at the meeting shall be the act of such class or series or classes or series.
2.9 Voting Rights. For the purpose of determining
8-K
EX-4.3
CRVO
CervoMed Inc
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2.
Loss
425
EX-99.2
CRVO
CervoMed Inc
9 Aug 23
Business combination disclosure
4:02pm
will occur.
As of June 30, 2023, the holders of the preferred stock had the following rights and preferences.
Voting Rights
Each holder
8-K
EX-99.2
CRVO
CervoMed Inc
9 Aug 23
Other Events
4:02pm
will occur.
As of June 30, 2023, the holders of the preferred stock had the following rights and preferences.
Voting Rights
Each holder
425
EX-10.1
p9oj7e4k0ml1prn9 9gz
30 Mar 23
Business combination disclosure
8:51am
425
EX-99.1
95ku81h6avlm5j m8x9
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-99.1
1y1i75xmq11326uhu
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-10.1
izg3algpz 6bn7
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
PRRN14A
gxt0vcldsvzlvtmj
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
PRRN14A
em0gbtk ph
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
PREC14A
xu25f cuxldcr1chs
23 Nov 22
Preliminary proxy with contested solicitation
11:26am
424B5
ckucnkut3
22 Jul 22
Prospectus supplement for primary offering
4:15pm
DEFA14A
9st7 hpv26g9z4xu
30 Mar 22
Additional proxy soliciting materials
4:33pm